Glucocorticoid: Clinical Trials

3 trials for Glucocorticoid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Completed 1, Recruiting 1
Phase 31Recruiting 1

Follow Glucocorticoid: new trials by email Literature Review of Glucocorticoid trials Research Report on Glucocorticoid

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy
Dexamethasone - Analgetic, Lung Cancer (NSCLC)
Phase 2 / Phase 3RecruitingCopenhagen University Hospital, Rigshospitalet802025-09-012026-01-07
Dapagliflozin as Prophylaxis for Glucocorticoid-Induced Hyperglycemia
Dapagliflozin (DAPA) - Dapagliflozin (Forxiga), Hyperglycaemia
Phase 2Active not recruitingLauro Fabián Amador Medina382024-12-012024-12-27
Evaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained Men
Mifepristone, Placebo, Spironolactone - Cortisol Resistance, Negative Feedback
Phase 2CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)512011-01-242024-07-15

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)  ·  Hyperglycemia (1)  ·  Lung Neoplasms (1)  ·  Motor Activity (1)

Broader conditions

Behavior (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Glucose Metabolism Disorders (1)  ·  Lung Diseases (1)  ·  Metabolic Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

Dexamethasone (2)  ·  Mifepristone (1)  ·  Spironolactone (1)  ·  dapagliflozin (1)

Sponsors

Copenhagen University Hospital, Rigshospitalet (1)  ·  Lauro Fabián Amador Medina (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Countries

Denmark (1)  ·  Mexico (1)  ·  United States (1)

Top investigators

Lauro F Amador Medina, Dr (1)  ·  Lynnette K Nieman, M.D. (1)

NIH funding

2025 (1)